ReWalk Robotics Ltd.

Equities

LFWD

IL0011331076

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
5.23 USD +0.97% Intraday chart for ReWalk Robotics Ltd. -1.32% -3.93%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ReWalk Robotics Set to Complete 1-for-7 Reverse Split of Ordinary Stock MT
ReWalk Robotics Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Transcript : ReWalk Robotics Ltd., Q4 2023 Earnings Call, Feb 27, 2024
Rewalk Robotics Ltd. Provides Earnings Guidance for the Full Year and First Quarter of 2024 CI
Earnings Flash (LFWD) REWALK ROBOTICS Reports Q4 Revenue $6.9M MT
ReWalk Robotics Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) added to NASDAQ Composite Index CI
ReWalk Robotics Ltd. will Change its Name to Lifeward CI
ReWalk Robotics Ltd. will Change its Ticker to LFWD from RWLK CI
ReWalk Robotics Ltd.(NasdaqCM:LFWD) dropped from NASDAQ Composite Index CI
ReWalk Robotics Expands Direct Sales to Canada; Shares Rise MT
ReWalk Robotics Says It Successfully Demonstrates Exoskeleton Prototype MT
ReWalk Robotics Demonstrates AI Autonomous Decision Making in Next Generation Exoskeleton Prototype CI
ReWalk Robotics Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : ReWalk Robotics Ltd., Q3 2023 Earnings Call, Nov 14, 2023
Earnings Flash (RWLK) REWALK ROBOTICS Reports Q3 Revenue $4.4M MT
Transcript : ReWalk Robotics Ltd. - Special Call
ReWalk Robotics Ltd. Announces Board Changes CI
Declaration of Voting Results by ReWalk Robotics CI
ReWalk Robotics Ltd. Announces Yasushi Ichiki Intends to Resign from Board of Directors CI
ReWalk Robotics Completes Acquisition of AlterG MT
ReWalk Robotics Ltd. Appoints Charles Remsberg as Chief Sales Officer CI
Tranche Update on ReWalk Robotics Ltd.'s Equity Buyback Plan announced on June 2, 2022. CI
Tranche Update on ReWalk Robotics Ltd.'s Equity Buyback Plan announced on June 2, 2022. CI
Transcript : ReWalk Robotics Ltd., Q2 2023 Earnings Call, Aug 11, 2023
Chart ReWalk Robotics Ltd.
More charts
ReWalk Robotics Ltd. doing business as Lifeward is a medical device company. The Company is engaged in designing, developing, and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk again. The Company offers an exoskeleton that uses its tilt-sensor technology and an onboard computer and motion sensors to drive motorized legs that power movement. Lifeward designs are intended for people with paraplegia, a spinal cord injury resulting in complete or incomplete paralysis of the legs, having the use of their upper bodies and arms. The Company offers multiple products: ReWalk Personal, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. ReWalk Personal is designed for everyday use by paraplegic individuals at home and in their communities and is custom-fitted for each user. Lifeward Rehabilitation products are for use by paraplegia patients in the clinical rehabilitation environment.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
5.23 USD
Average target price
21 USD
Spread / Average Target
+301.53%
Consensus
  1. Stock
  2. Equities
  3. Stock ReWalk Robotics Ltd. - Nasdaq
  4. News ReWalk Robotics Ltd.
  5. ReWalk Robotics : Health Care Stocks Retreating to Begin New Week